- Home
- XNCR vs VTEX Comparison
XNCR vs VTEX Comparison
Compare XNCR & VTEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XNCR
- VTEX
- Stock Information
- Founded
- XNCR 1997
- VTEX 1999
- Country
- XNCR United States
- VTEX United Kingdom
- Employees
- XNCR N/A
- VTEX N/A
- Industry
- XNCR Biotechnology: Pharmaceutical Preparations
- VTEX Computer Software: Prepackaged Software
- Sector
- XNCR Health Care
- VTEX Technology
- Exchange
- XNCR Nasdaq
- VTEX Nasdaq
- Market Cap
- XNCR 1.5B
- VTEX 1.2B
- IPO Year
- XNCR 2013
- VTEX 2021
- Fundamental
- Price
- XNCR $24.10
- VTEX $6.38
- Analyst Decision
- XNCR Strong Buy
- VTEX Buy
- Analyst Count
- XNCR 8
- VTEX 6
- Target Price
- XNCR $35.50
- VTEX $10.17
- AVG Volume (30 Days)
- XNCR 569.4K
- VTEX 465.8K
- Earning Date
- XNCR 11-06-2024
- VTEX 11-05-2024
- Dividend Yield
- XNCR N/A
- VTEX N/A
- EPS Growth
- XNCR N/A
- VTEX N/A
- EPS
- XNCR N/A
- VTEX 0.05
- Revenue
- XNCR $85,164,000.00
- VTEX $225,906,000.00
- Revenue This Year
- XNCR N/A
- VTEX $18.68
- Revenue Next Year
- XNCR $86.53
- VTEX $20.90
- P/E Ratio
- XNCR N/A
- VTEX $135.45
- Revenue Growth
- XNCR N/A
- VTEX 21.27
- 52 Week Low
- XNCR $15.31
- VTEX $5.72
- 52 Week High
- XNCR $26.84
- VTEX $9.59
- Technical
- Relative Strength Index (RSI)
- XNCR 70.71
- VTEX 38.00
- Support Level
- XNCR $22.60
- VTEX $6.12
- Resistance Level
- XNCR $23.86
- VTEX $6.62
- Average True Range (ATR)
- XNCR 0.83
- VTEX 0.24
- MACD
- XNCR 0.05
- VTEX -0.03
- Stochastic Oscillator
- XNCR 96.85
- VTEX 30.72
About XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.
About VTEX VTEX
Vtex provides a software-as-a-service digital commerce platform for enterprise brands and retailers. Its platform enables customers to execute their commerce plan, including building online stores, integrating and managing orders across channels, and creating marketplaces to sell products from third-party vendors. It generates maximum revenues from Brazil followed by Latin America and the rest of the world.